Cardiovascular-kidney-metabolic syndrome stages and risk of diverse gastrointestinal diseases: a prospective cohort study and integrative proteomic analysis

Diabetes Res Clin PractPublished Prospective cohort study

Main finding · Overall GI disease riskResult — go to the resultAdjusted hazard ratio 1.91 95% CI 1.84–2.00

Authors' conclusion

Advanced CKM stages significantly elevate the risk of diverse GI diseases. Specific circulating proteomic signatures underlie these systemic associations. Integrating cardiometabolic profiling into GI risk stratification holds early preventive potential, requiring external validation before clinical implementation.

Study context

Population
UK Biobank participants (cardiovascular-kidney-metabolic (CKM) stages 0–4) free of baseline gastrointestinal (GI) diseasesproteomics n = 38,031
Participants
354,444 participants
Exposure
CKM stages 1-4 vs stage 0
Outcome
Incident functional, inflammatory and malignant GI diseases
Follow-up
Median 13.2 years
Methodological detailsintegrative proteomic analysis, mediation modeling
  • Integrative proteomic analysis
  • Mediation modeling

Main finding

Overall GI disease risk

Adjusted hazard ratio

1.91

95% CI 1.84–2.00

Stage 4vs Stage 0
adjusted HR 1.91 (95% CI 1.84–2.00)

As reported in the abstract

GI cases
81,168
Population attributable fraction of CKM stages 1-4
27.1%

Observational data: associations, not effects.

Further findings

Subgroups by sex and age

Associations stronger in females and individuals < 60 years, except higher male susceptibility to colorectal cancer

Proteomic mediation

Immune-inflammatory networks underpinned functional and inflammatory diseases; GI cancers enriched in pro-proliferative pathways
HGF, GDF15 and PLAUR emerged as core shared targets

Original publication

Cardiovascular-kidney-metabolic syndrome stages and risk of diverse gastrointestinal diseases: a prospective cohort study and integrative proteomic analysis. Diabetes Res Clin Pract. Published 16 April 2026. doi:10.1016/j.diabres.2026.113266

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.